PTC Therapeutics
PTCT
#3002
Rank
S$6.92 B
Marketcap
S$86.23
Share price
0.13%
Change (1 day)
15.63%
Change (1 year)

PTC Therapeutics (PTCT) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : S$3.53 Billion

According to PTC Therapeutics 's latest financial reports the company's total liabilities are S$3.53 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

PTC Therapeutics - Total liabilities on balance sheet (from 2012 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31S$3.81 B6.29%
2023-12-31S$3.58 B30.27%
2022-12-31S$2.75 B5.11%
2021-12-31S$2.61 B14.64%
2020-12-31S$2.28 B64.55%
2019-12-31S$1.38 B32.19%
2018-12-31S$1.04 B233.72%
2017-12-31S$0.31 B45.14%
2016-12-31S$0.21 B10.02%
2015-12-31S$0.19 B329.05%
2014-12-31S$45.91 M135.94%
2013-12-31S$19.46 M-50.68%
2012-12-31S$39.45 M-89.22%
2011-12-31S$0.36 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Novartis
NVS
S$81.43 B 2,200.44%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Vertex Pharmaceuticals
VRTX
S$9.53 B 169.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
S$0.30 B-91.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
S$2.74 B-22.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Fate Therapeutics
FATE
S$0.13 B-96.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Avidity Biosciences
RNA
S$0.31 B-91.14%๐Ÿ‡บ๐Ÿ‡ธ USA